25 XP   0   0   10

United Therapeutics Corporation
Buy, Hold or Sell?

Let's analyse United Therapeutics Corporation together

PenkeI guess you are interested in United Therapeutics Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of United Therapeutics Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about United Therapeutics Corporation

I send you an email if I find something interesting about United Therapeutics Corporation.

Quick analysis of United Therapeutics Corporation (30 sec.)










What can you expect buying and holding a share of United Therapeutics Corporation? (30 sec.)

How much money do you get?

How much money do you get?
$0.15
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
$120.18
Expected worth in 1 year
$143.25
How sure are you?
85.0%

+ What do you gain per year?

Total Gains per Share
$23.22
Return On Investment
9.8%

For what price can you sell your share?

Current Price per Share
$236.93
Expected price per share
$208.62 - $250.89
How sure are you?
50%

1. Valuation of United Therapeutics Corporation (5 min.)




Live pricePrice per Share (EOD)

$236.93

Intrinsic Value Per Share

$25.27 - $105.61

Total Value Per Share

$145.44 - $225.79

2. Growth of United Therapeutics Corporation (5 min.)




Is United Therapeutics Corporation growing?

Current yearPrevious yearGrowGrow %
How rich?$5.9b$4.4b$1b19.7%

How much money is United Therapeutics Corporation making?

Current yearPrevious yearGrowGrow %
Making money$246.2m$181.8m$64.3m26.1%
Net Profit Margin42.6%37.5%--

How much money comes from the company's main activities?

3. Financial Health of United Therapeutics Corporation (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#12 / 1016

Most Revenue
#32 / 1016

Most Profit
#20 / 1016

Most Efficient
#33 / 1016

What can you expect buying and holding a share of United Therapeutics Corporation? (5 min.)

Welcome investor! United Therapeutics Corporation's management wants to use your money to grow the business. In return you get a share of United Therapeutics Corporation.

What can you expect buying and holding a share of United Therapeutics Corporation?

First you should know what it really means to hold a share of United Therapeutics Corporation. And how you can make/lose money.

Speculation

The Price per Share of United Therapeutics Corporation is $236.93. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of United Therapeutics Corporation.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in United Therapeutics Corporation, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $120.18. Based on the TTM, the Book Value Change Per Share is $5.77 per quarter. Based on the YOY, the Book Value Change Per Share is $3.57 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of United Therapeutics Corporation.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps4.361.8%4.962.1%3.761.6%2.681.1%2.731.2%
Usd Book Value Change Per Share5.252.2%5.772.4%3.571.5%3.051.3%2.361.0%
Usd Dividend Per Share0.150.1%0.040.0%0.020.0%0.200.1%0.120.0%
Usd Total Gains Per Share5.392.3%5.812.5%3.591.5%3.251.4%2.471.0%
Usd Price Per Share219.89-222.62-225.63-168.61-147.96-
Price to Earnings Ratio12.61-11.29-17.50-15.42-9.18-
Price-to-Total Gains Ratio40.78-38.45-69.56-48.17-78.80-
Price to Book Ratio1.83-2.00-2.44-2.04-2.94-
Price-to-Total Gains Ratio40.78-38.45-69.56-48.17-78.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share236.93
Number of shares4
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.20
Usd Book Value Change Per Share5.773.05
Usd Total Gains Per Share5.813.25
Gains per Quarter (4 shares)23.2212.99
Gains per Year (4 shares)92.9051.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11928334942
2118517669794
3227726910146146
4236936213195198
5346245516244250
6455454819292302
7464664122341354
8573873426390406
9583182729439458
10692392032487510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%36.04.00.090.0%71.029.00.071.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%33.07.00.082.5%73.027.00.073.0%
Dividend per Share1.00.03.025.0%2.00.010.016.7%5.00.015.025.0%10.00.030.025.0%10.00.090.010.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%34.06.00.085.0%74.026.00.074.0%

Fundamentals of United Therapeutics Corporation

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for treating high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, the company engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.

Fundamental data was last updated by Penke on 2024-04-12 21:12:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of United Therapeutics Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit United Therapeutics Corporation earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare United Therapeutics Corporation to the Biotechnology industry mean.
  • A Net Profit Margin of 35.3% means that $0.35 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of United Therapeutics Corporation:

  • The MRQ is 35.3%. The company is making a huge profit. +2
  • The TTM is 42.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ35.3%TTM42.6%-7.2%
TTM42.6%YOY37.5%+5.0%
TTM42.6%5Y26.9%+15.7%
5Y26.9%10Y31.0%-4.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ35.3%-197.2%+232.5%
TTM42.6%-210.4%+253.0%
YOY37.5%-279.3%+316.8%
5Y26.9%-436.8%+463.7%
10Y31.0%-599.3%+630.3%
1.1.2. Return on Assets

Shows how efficient United Therapeutics Corporation is using its assets to generate profit.

  • Above 5% is considered healthy but always compare United Therapeutics Corporation to the Biotechnology industry mean.
  • 3.0% Return on Assets means that United Therapeutics Corporation generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of United Therapeutics Corporation:

  • The MRQ is 3.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.0%TTM3.6%-0.6%
TTM3.6%YOY3.2%+0.4%
TTM3.6%5Y2.3%+1.3%
5Y2.3%10Y4.0%-1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0%-13.6%+16.6%
TTM3.6%-12.9%+16.5%
YOY3.2%-11.9%+15.1%
5Y2.3%-14.2%+16.5%
10Y4.0%-16.2%+20.2%
1.1.3. Return on Equity

Shows how efficient United Therapeutics Corporation is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare United Therapeutics Corporation to the Biotechnology industry mean.
  • 3.6% Return on Equity means United Therapeutics Corporation generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of United Therapeutics Corporation:

  • The MRQ is 3.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.6%TTM4.5%-0.8%
TTM4.5%YOY4.1%+0.3%
TTM4.5%5Y2.8%+1.6%
5Y2.8%10Y5.3%-2.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%-17.0%+20.6%
TTM4.5%-16.1%+20.6%
YOY4.1%-15.4%+19.5%
5Y2.8%-20.0%+22.8%
10Y5.3%-21.1%+26.4%

1.2. Operating Efficiency of United Therapeutics Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient United Therapeutics Corporation is operating .

  • Measures how much profit United Therapeutics Corporation makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare United Therapeutics Corporation to the Biotechnology industry mean.
  • An Operating Margin of 50.5% means the company generated $0.51  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of United Therapeutics Corporation:

  • The MRQ is 50.5%. The company is operating very efficient. +2
  • The TTM is 53.2%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ50.5%TTM53.2%-2.7%
TTM53.2%YOY48.1%+5.1%
TTM53.2%5Y34.1%+19.1%
5Y34.1%10Y43.5%-9.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ50.5%-286.1%+336.6%
TTM53.2%-224.4%+277.6%
YOY48.1%-288.4%+336.5%
5Y34.1%-475.2%+509.3%
10Y43.5%-624.7%+668.2%
1.2.2. Operating Ratio

Measures how efficient United Therapeutics Corporation is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.58 means that the operating costs are $0.58 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of United Therapeutics Corporation:

  • The MRQ is 0.577. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.488. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.488+0.088
TTM0.488YOY0.494-0.006
TTM0.4885Y0.681-0.193
5Y0.68110Y0.575+0.106
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5772.997-2.420
TTM0.4883.247-2.759
YOY0.4943.766-3.272
5Y0.6815.675-4.994
10Y0.5757.857-7.282

1.3. Liquidity of United Therapeutics Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if United Therapeutics Corporation is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.41 means the company has $4.41 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of United Therapeutics Corporation:

  • The MRQ is 4.414. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.894. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.414TTM6.894-2.480
TTM6.894YOY9.116-2.221
TTM6.8945Y7.171-0.276
5Y7.17110Y5.145+2.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4143.930+0.484
TTM6.8944.251+2.643
YOY9.1165.436+3.680
5Y7.1716.045+1.126
10Y5.1456.363-1.218
1.3.2. Quick Ratio

Measures if United Therapeutics Corporation is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare United Therapeutics Corporation to the Biotechnology industry mean.
  • A Quick Ratio of 6.29 means the company can pay off $6.29 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of United Therapeutics Corporation:

  • The MRQ is 6.290. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.036. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.290TTM14.036-7.746
TTM14.036YOY14.371-0.336
TTM14.0365Y11.605+2.430
5Y11.60510Y7.549+4.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2903.629+2.661
TTM14.0364.065+9.971
YOY14.3715.397+8.974
5Y11.6055.993+5.612
10Y7.5496.277+1.272

1.4. Solvency of United Therapeutics Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of United Therapeutics Corporation assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare United Therapeutics Corporation to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.16 means that United Therapeutics Corporation assets are financed with 16.5% credit (debt) and the remaining percentage (100% - 16.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of United Therapeutics Corporation:

  • The MRQ is 0.165. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.184. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.165TTM0.184-0.019
TTM0.184YOY0.215-0.031
TTM0.1845Y0.248-0.064
5Y0.24810Y0.262-0.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1650.332-0.167
TTM0.1840.334-0.150
YOY0.2150.268-0.053
5Y0.2480.366-0.118
10Y0.2620.390-0.128
1.4.2. Debt to Equity Ratio

Measures if United Therapeutics Corporation is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare United Therapeutics Corporation to the Biotechnology industry mean.
  • A Debt to Equity ratio of 19.8% means that company has $0.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of United Therapeutics Corporation:

  • The MRQ is 0.198. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.225. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.198TTM0.225-0.028
TTM0.225YOY0.274-0.048
TTM0.2255Y0.336-0.111
5Y0.33610Y0.368-0.032
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1980.381-0.183
TTM0.2250.390-0.165
YOY0.2740.334-0.060
5Y0.3360.434-0.098
10Y0.3680.466-0.098

2. Market Valuation of United Therapeutics Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings United Therapeutics Corporation generates.

  • Above 15 is considered overpriced but always compare United Therapeutics Corporation to the Biotechnology industry mean.
  • A PE ratio of 12.61 means the investor is paying $12.61 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of United Therapeutics Corporation:

  • The EOD is 13.587. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.610. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.291. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD13.587MRQ12.610+0.977
MRQ12.610TTM11.291+1.319
TTM11.291YOY17.499-6.208
TTM11.2915Y15.419-4.128
5Y15.41910Y9.177+6.242
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD13.587-2.315+15.902
MRQ12.610-2.560+15.170
TTM11.291-2.664+13.955
YOY17.499-4.122+21.621
5Y15.419-6.258+21.677
10Y9.177-6.108+15.285
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of United Therapeutics Corporation:

  • The EOD is 40.969. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 38.023. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 25.176. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD40.969MRQ38.023+2.947
MRQ38.023TTM25.176+12.847
TTM25.176YOY21.421+3.754
TTM25.1765Y16.326+8.849
5Y16.32610Y5.728+10.598
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD40.969-3.067+44.036
MRQ38.023-3.251+41.274
TTM25.176-3.545+28.721
YOY21.421-5.595+27.016
5Y16.326-8.315+24.641
10Y5.728-8.708+14.436
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of United Therapeutics Corporation is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.83 means the investor is paying $1.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of United Therapeutics Corporation:

  • The EOD is 1.972. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.830. Based on the equity, the company is underpriced. +1
  • The TTM is 1.996. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.972MRQ1.830+0.142
MRQ1.830TTM1.996-0.166
TTM1.996YOY2.443-0.448
TTM1.9965Y2.042-0.047
5Y2.04210Y2.940-0.898
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9721.905+0.067
MRQ1.8302.111-0.281
TTM1.9962.095-0.099
YOY2.4432.836-0.393
5Y2.0423.443-1.401
10Y2.9403.794-0.854
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of United Therapeutics Corporation.

3.1. Institutions holding United Therapeutics Corporation

Institutions are holding 97.016% of the shares of United Therapeutics Corporation.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc11.25190.029752950001833953.5878
2023-12-31Vanguard Group Inc9.93160.02254673678107670.2309
2023-12-31Wellington Management Company LLP8.06230.15553794010-327803-7.9529
2023-12-31venBio Select Advisor LLC6.07528.6832285888863880.2239
2023-12-31FMR Inc4.93220.03922321040-283749-10.8934
2023-12-31Renaissance Technologies Corp4.61170.73862170214-80294-3.5678
2023-12-31State Street Corporation4.13780.02081947177679073.6135
2023-12-31HHG PLC1.8490.1141870119-6449-0.7357
2023-12-31Geode Capital Management, LLC1.6570.0179779762-50484-6.0806
2023-12-31Dimensional Fund Advisors, Inc.1.19420.036156195099621.8047
2023-12-31Bank of New York Mellon Corp1.1770.0247553868-17200-3.0119
2023-12-31AQR Capital Management LLC1.17250.22725517677517915.7744
2023-12-31Nuveen Asset Management, LLC1.04450.0348491505-21876-4.2612
2023-12-31Farallon Capital Management, L.L.C.1.01150.51964760004760000
2023-12-31Morgan Stanley - Brokerage Accounts0.97690.008945973210533129.7209
2023-12-31NORGES BANK0.97140.0176457132106662.389
2023-12-31Fuller & Thaler Asset Management Inc0.91610.48034311162160.0501
2023-12-31Palo Alto Investors, LLC0.8417.8411395784-180123-31.2764
2023-12-31Orbimed Advisors, LLC0.82051.6955386100-15800-3.9313
2023-12-31LSV Asset Management0.80190.1811377368-5700-1.488
Total 63.436220.888429852210-43667-0.1%

3.2. Funds holding United Therapeutics Corporation

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.13360.02151474645-3300-0.2233
2024-03-28iShares Core S&P Mid-Cap ETF3.10730.39491462268-807-0.0552
2024-02-29Vanguard Small Cap Index2.57410.19451211331112540.9378
2023-12-31Vanguard Health Care Inv1.79050.399284259300
2024-02-29Vanguard Small Cap Value Index Inv1.75560.350682614042340.5151
2023-09-30Federated Hermes Kaufmann Small Cap Grow1.748082257000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.47450.153469385718140.2621
2023-12-31Vanguard Windsor Investor Shares1.15140.503541854-6138-1.1201
2024-03-28Pacer US Cash Cows 100 ETF0.97640.46744594728260.1801
2023-12-31FullerThaler Behavioral Small-Cap Equity0.86431.124640673200
2023-12-31FullerThaler Behavioral Sm-Cp Eq R60.86431.124940673200
2024-02-29SPDR® S&P MIDCAP 400 ETF Trust0.79660.402337485514100.3776
2024-03-28iShares Biotechnology ETF0.69130.9793325324-566-0.1737
2024-03-28SPDR® S&P Biotech ETF0.6680.956331435139601.2758
2024-02-29Hartford MidCap Y0.61941.0137291502-49612-14.5441
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.58520.148827540775002.7995
2024-02-29Fidelity Extended Market Index0.56220.155626457624900.9501
2023-12-31Janus Henderson Research D0.54740.294125760100
2023-12-31Janus Henderson US Research Growth Eq0.54740.294925760100
2023-12-31Worldwide Healthcare Ord0.47581.968122390000
Total 24.933310.947111733311-26935-0.2%

3.3. Insider Transactions

Insiders are holding 1.72% of the shares of United Therapeutics Corporation.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-10Martine A RothblattSELL13800237.27
2024-04-08Martine A RothblattSELL5060237.52
2024-04-04Martine A RothblattSELL15000233.27
2024-04-04Paul A MahonSELL6000232.37
2024-03-28Martine A RothblattSELL14125236.18
2024-03-27Nilda MesaSELL325237.8
2024-03-26Martine A RothblattSELL15000248.33
2024-03-22Martine A RothblattSELL15000237.05
2024-03-21Paul A MahonSELL6000236.45
2024-03-19Martine A RothblattSELL15000236.59
2024-02-23Christopher PatuskySELL1680224
2024-02-15Paul A MahonSELL6000215.31
2024-02-01Paul A MahonSELL6000215.01
2024-01-18Paul A MahonSELL6000218.72
2024-01-04Paul A MahonSELL6000227.97
2023-12-21Paul A MahonSELL6000229.27
2023-12-19Nilda MesaSELL605244.9
2023-12-12Christopher CauseySELL3000249.68
2023-12-07Paul A MahonSELL6000238.89
2023-11-02Paul A MahonSELL6000225.76

4. Summary

4.1. Key Performance Indicators

The key performance indicators of United Therapeutics Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--5.2455.769-9%3.569+47%3.046+72%2.356+123%
Book Value Per Share--120.177111.928+7%92.028+31%81.030+48%59.226+103%
Current Ratio--4.4146.894-36%9.116-52%7.171-38%5.145-14%
Debt To Asset Ratio--0.1650.184-10%0.215-23%0.248-33%0.262-37%
Debt To Equity Ratio--0.1980.225-12%0.274-28%0.336-41%0.368-46%
Dividend Per Share--0.1470.037+300%0.017+748%0.201-27%0.116+26%
Eps--4.3594.959-12%3.757+16%2.680+63%2.727+60%
Free Cash Flow Per Share--1.4463.764-62%3.437-58%2.375-39%2.348-38%
Free Cash Flow To Equity Per Share---0.4183.707-111%3.821-111%3.118-113%1.988-121%
Gross Profit Margin--0.8890.916-3%0.889+0%0.871+2%0.889+0%
Intrinsic Value_10Y_max--105.610--------
Intrinsic Value_10Y_min--25.266--------
Intrinsic Value_1Y_max--12.629--------
Intrinsic Value_1Y_min--8.279--------
Intrinsic Value_3Y_max--36.386--------
Intrinsic Value_3Y_min--20.044--------
Intrinsic Value_5Y_max--58.262--------
Intrinsic Value_5Y_min--26.426--------
Market Cap11149570405.000+2%10950522000.00011052950500.000-1%10956648250.0000%8132869249.125+35%7166552437.375+53%
Net Profit Margin--0.3530.426-17%0.375-6%0.269+31%0.310+14%
Operating Margin--0.5050.532-5%0.481+5%0.341+48%0.435+16%
Operating Ratio--0.5770.488+18%0.494+17%0.681-15%0.575+0%
Pb Ratio1.972+7%1.8301.996-8%2.443-25%2.042-10%2.940-38%
Pe Ratio13.587+7%12.61011.291+12%17.499-28%15.419-18%9.177+37%
Price Per Share236.930+7%219.890222.618-1%225.630-3%168.610+30%147.963+49%
Price To Free Cash Flow Ratio40.969+7%38.02325.176+51%21.421+78%16.326+133%5.728+564%
Price To Total Gains Ratio43.943+7%40.78338.453+6%69.559-41%48.173-15%78.801-48%
Quick Ratio--6.29014.036-55%14.371-56%11.605-46%7.549-17%
Return On Assets--0.0300.036-17%0.032-6%0.023+33%0.040-24%
Return On Equity--0.0360.045-19%0.041-12%0.028+28%0.053-31%
Total Gains Per Share--5.3925.806-7%3.587+50%3.247+66%2.472+118%
Usd Book Value--5984800000.0005557775000.000+8%4463400000.000+34%3903995000.000+53%2854138125.000+110%
Usd Book Value Change Per Share--5.2455.769-9%3.569+47%3.046+72%2.356+123%
Usd Book Value Per Share--120.177111.928+7%92.028+31%81.030+48%59.226+103%
Usd Dividend Per Share--0.1470.037+300%0.017+748%0.201-27%0.116+26%
Usd Eps--4.3594.959-12%3.757+16%2.680+63%2.727+60%
Usd Free Cash Flow--72000000.000186900000.000-61%165924999.750-57%114739999.950-37%112947224.975-36%
Usd Free Cash Flow Per Share--1.4463.764-62%3.437-58%2.375-39%2.348-38%
Usd Free Cash Flow To Equity Per Share---0.4183.707-111%3.821-111%3.118-113%1.988-121%
Usd Market Cap11149570405.000+2%10950522000.00011052950500.000-1%10956648250.0000%8132869249.125+35%7166552437.375+53%
Usd Price Per Share236.930+7%219.890222.618-1%225.630-3%168.610+30%147.963+49%
Usd Profit--217100000.000246200000.000-12%181825000.000+19%129910000.000+67%132767825.000+64%
Usd Revenue--614700000.000581875000.000+6%484075000.000+27%444070000.000+38%414689475.000+48%
Usd Total Gains Per Share--5.3925.806-7%3.587+50%3.247+66%2.472+118%
 EOD+4 -4MRQTTM+11 -25YOY+20 -165Y+24 -1210Y+22 -14

4.2. Fundamental Score

Let's check the fundamental score of United Therapeutics Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.587
Price to Book Ratio (EOD)Between0-11.972
Net Profit Margin (MRQ)Greater than00.353
Operating Margin (MRQ)Greater than00.505
Quick Ratio (MRQ)Greater than16.290
Current Ratio (MRQ)Greater than14.414
Debt to Asset Ratio (MRQ)Less than10.165
Debt to Equity Ratio (MRQ)Less than10.198
Return on Equity (MRQ)Greater than0.150.036
Return on Assets (MRQ)Greater than0.050.030
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of United Therapeutics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.271
Ma 20Greater thanMa 50235.810
Ma 50Greater thanMa 100230.761
Ma 100Greater thanMa 200229.244
OpenGreater thanClose234.670
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets7,167,000
Total Liabilities1,182,200
Total Stockholder Equity5,984,800
 As reported
Total Liabilities 1,182,200
Total Stockholder Equity+ 5,984,800
Total Assets = 7,167,000

Assets

Total Assets7,167,000
Total Current Assets3,551,000
Long-term Assets3,616,000
Total Current Assets
Cash And Cash Equivalents 1,207,700
Short-term Investments 1,786,400
Net Receivables 278,900
Inventory 111,800
Other Current Assets 166,200
Total Current Assets  (as reported)3,551,000
Total Current Assets  (calculated)3,551,000
+/-0
Long-term Assets
Property Plant Equipment 1,045,400
Goodwill 33,700
Long Term Investments 1,909,800
Intangible Assets 80,500
Long-term Assets Other 151,800
Long-term Assets  (as reported)3,616,000
Long-term Assets  (calculated)3,221,200
+/- 394,800

Liabilities & Shareholders' Equity

Total Current Liabilities804,400
Long-term Liabilities377,800
Total Stockholder Equity5,984,800
Total Current Liabilities
Short-term Debt 400,000
Short Long Term Debt 400,000
Accounts payable 5,600
Other Current Liabilities 71,000
Total Current Liabilities  (as reported)804,400
Total Current Liabilities  (calculated)876,600
+/- 72,200
Long-term Liabilities
Long term Debt 300,000
Long-term Liabilities Other 77,800
Long-term Liabilities  (as reported)377,800
Long-term Liabilities  (calculated)377,800
+/-0
Total Stockholder Equity
Common Stock700
Retained Earnings 6,027,100
Accumulated Other Comprehensive Income -12,800
Other Stockholders Equity -30,200
Total Stockholder Equity (as reported)5,984,800
Total Stockholder Equity (calculated)5,984,800
+/-0
Other
Capital Stock700
Cash and Short Term Investments 2,994,100
Common Stock Shares Outstanding 49,800
Current Deferred Revenue327,800
Liabilities and Stockholders Equity 7,167,000
Net Debt -507,700
Net Invested Capital 6,684,800
Net Working Capital 2,746,600
Property Plant and Equipment Gross 1,473,600
Short Long Term Debt Total 700,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-31
> Total Assets 
17,800
59,900
63,500
59,900
130,405
123,373
252,441
250,645
240,999
229,841
218,078
212,121
202,198
200,604
187,473
184,566
181,980
184,668
188,086
179,502
176,040
183,250
195,110
207,158
216,925
234,224
257,173
291,413
304,751
325,433
297,774
478,550
436,266
471,794
512,718
587,018
638,064
679,818
766,680
871,319
902,813
951,671
1,004,727
1,051,544
1,126,703
1,187,675
1,282,784
1,431,635
1,485,404
1,578,740
1,667,053
1,518,079
1,561,435
1,556,401
1,647,492
1,626,595
1,697,355
1,777,673
1,927,657
2,087,567
2,114,934
1,952,872
2,072,050
1,884,410
1,894,614
1,736,822
2,159,233
2,184,445
2,192,100
2,201,500
2,269,200
2,325,600
2,561,300
2,691,500
2,936,000
2,879,400
3,020,200
3,244,900
3,412,100
3,401,000
3,726,700
3,898,900
3,999,600
3,913,400
4,025,900
4,219,400
4,411,200
4,615,000
4,641,000
4,844,900
5,048,900
5,169,100
5,359,800
5,543,300
5,781,600
6,044,500
6,346,000
6,681,300
7,023,600
7,167,000
7,167,0007,023,6006,681,3006,346,0006,044,5005,781,6005,543,3005,359,8005,169,1005,048,9004,844,9004,641,0004,615,0004,411,2004,219,4004,025,9003,913,4003,999,6003,898,9003,726,7003,401,0003,412,1003,244,9003,020,2002,879,4002,936,0002,691,5002,561,3002,325,6002,269,2002,201,5002,192,1002,184,4452,159,2331,736,8221,894,6141,884,4102,072,0501,952,8722,114,9342,087,5671,927,6571,777,6731,697,3551,626,5951,647,4921,556,4011,561,4351,518,0791,667,0531,578,7401,485,4041,431,6351,282,7841,187,6751,126,7031,051,5441,004,727951,671902,813871,319766,680679,818638,064587,018512,718471,794436,266478,550297,774325,433304,751291,413257,173234,224216,925207,158195,110183,250176,040179,502188,086184,668181,980184,566187,473200,604202,198212,121218,078229,841240,999250,645252,441123,373130,40559,90063,50059,90017,800
   > Total Current Assets 
15,500
57,800
59,800
52,700
118,502
111,598
240,835
222,120
197,762
172,118
107,025
69,003
77,354
169,697
155,155
141,857
110,199
111,202
105,327
89,721
88,288
95,391
107,959
110,492
119,306
126,631
146,891
166,757
186,670
207,263
180,196
277,374
218,921
246,835
286,876
352,461
327,860
282,641
295,923
297,447
267,361
287,878
322,151
324,507
398,745
516,292
598,484
764,487
810,844
877,509
846,133
562,455
573,919
570,607
718,185
668,470
844,567
903,583
932,742
909,013
990,268
881,608
1,078,485
974,197
994,091
829,039
1,228,523
1,275,335
1,299,600
1,315,400
1,386,000
1,424,800
1,504,100
1,563,700
1,639,200
1,447,900
1,633,600
1,624,200
1,608,700
1,768,000
1,942,500
2,139,800
1,933,400
1,864,500
1,846,300
1,894,400
1,868,200
2,167,200
2,014,300
2,317,900
2,385,900
2,323,600
2,586,600
2,684,300
3,056,400
3,380,300
3,193,000
3,213,400
3,458,900
3,551,000
3,551,0003,458,9003,213,4003,193,0003,380,3003,056,4002,684,3002,586,6002,323,6002,385,9002,317,9002,014,3002,167,2001,868,2001,894,4001,846,3001,864,5001,933,4002,139,8001,942,5001,768,0001,608,7001,624,2001,633,6001,447,9001,639,2001,563,7001,504,1001,424,8001,386,0001,315,4001,299,6001,275,3351,228,523829,039994,091974,1971,078,485881,608990,268909,013932,742903,583844,567668,470718,185570,607573,919562,455846,133877,509810,844764,487598,484516,292398,745324,507322,151287,878267,361297,447295,923282,641327,860352,461286,876246,835218,921277,374180,196207,263186,670166,757146,891126,631119,306110,492107,95995,39188,28889,721105,327111,202110,199141,857155,155169,69777,35469,003107,025172,118197,762222,120240,835111,598118,50252,70059,80057,80015,500
       Cash And Cash Equivalents 
15,400
4,500
5,800
18,300
102,788
95,039
224,288
200,935
183,404
163,291
86,479
24,373
20,726
15,546
133,807
122,655
91,238
91,067
86,443
68,562
68,521
74,481
86,378
82,586
82,812
56,533
71,019
69,180
87,619
71,322
48,504
91,067
67,851
81,482
73,538
139,323
177,646
125,332
107,973
129,452
98,848
133,524
134,502
100,352
189,956
285,409
210,186
252,162
288,963
321,121
343,984
162,676
156,666
157,013
263,425
154,030
262,126
343,550
322,230
278,889
413,794
259,046
497,291
397,697
426,509
254,359
765,205
831,798
846,800
837,500
953,000
1,023,000
1,122,600
1,005,900
1,067,500
705,100
932,700
745,900
656,000
669,200
790,600
881,300
719,700
738,400
875,200
685,400
670,200
738,700
832,300
942,200
908,500
894,800
813,300
795,200
966,800
961,200
1,163,500
1,067,300
1,107,700
1,207,700
1,207,7001,107,7001,067,3001,163,500961,200966,800795,200813,300894,800908,500942,200832,300738,700670,200685,400875,200738,400719,700881,300790,600669,200656,000745,900932,700705,1001,067,5001,005,9001,122,6001,023,000953,000837,500846,800831,798765,205254,359426,509397,697497,291259,046413,794278,889322,230343,550262,126154,030263,425157,013156,666162,676343,984321,121288,963252,162210,186285,409189,956100,352134,502133,52498,848129,452107,973125,332177,646139,32373,53881,48267,85191,06748,50471,32287,61969,18071,01956,53382,81282,58686,37874,48168,52168,56286,44391,06791,238122,655133,80715,54620,72624,37386,479163,291183,404200,935224,28895,039102,78818,3005,8004,50015,400
       Short-term Investments 
0
53,000
53,900
33,300
13,839
14,035
14,256
14,484
7,312
0
10,500
31,677
43,584
132,229
0
0
0
0
0
0
0
0
10,118
200
7,000
38,690
41,638
56,304
60,322
95,034
95,060
136,682
103,364
116,886
163,540
150,729
87,514
89,137
123,942
106,596
86,945
86,361
100,994
129,140
103,414
94,066
251,553
374,921
394,447
409,098
350,614
240,803
252,300
235,355
240,032
325,175
408,516
353,041
394,612
409,645
346,698
308,534
270,372
297,842
230,356
185,774
156,630
121,974
128,300
107,200
79,600
27,800
33,700
109,300
143,200
222,300
324,100
467,100
581,600
746,700
814,500
904,900
850,300
747,500
669,300
875,300
910,300
1,096,300
899,000
1,025,300
1,091,900
1,035,900
1,454,400
1,460,000
1,648,800
1,877,500
1,699,900
3,635,300
3,828,600
1,786,400
1,786,4003,828,6003,635,3001,699,9001,877,5001,648,8001,460,0001,454,4001,035,9001,091,9001,025,300899,0001,096,300910,300875,300669,300747,500850,300904,900814,500746,700581,600467,100324,100222,300143,200109,30033,70027,80079,600107,200128,300121,974156,630185,774230,356297,842270,372308,534346,698409,645394,612353,041408,516325,175240,032235,355252,300240,803350,614409,098394,447374,921251,55394,066103,414129,140100,99486,36186,945106,596123,94289,13787,514150,729163,540116,886103,364136,68295,06095,03460,32256,30441,63838,6907,00020010,11800000000132,22943,58431,67710,50007,31214,48414,25614,03513,83933,30053,90053,0000
       Net Receivables 
100
200
0
400
425
452
582
2,351
2,601
3,153
3,129
4,224
4,451
13,191
11,789
9,659
9,940
10,451
9,186
10,612
7,858
10,199
11,068
14,766
14,678
16,604
20,198
18,807
19,383
22,564
20,505
25,579
23,066
27,262
28,498
29,662
29,620
33,418
39,909
30,600
52,007
34,368
48,968
53,264
63,510
83,514
75,569
73,707
65,415
82,527
87,390
88,680
89,150
98,584
108,949
116,626
101,347
131,565
130,642
126,297
131,771
212,902
139,903
162,287
156,153
169,214
179,642
192,827
194,800
238,100
224,600
214,500
188,000
273,900
251,800
297,100
211,100
251,300
215,200
175,700
159,800
181,000
183,600
151,400
149,600
172,000
152,300
157,400
141,100
173,400
212,800
198,700
170,500
173,400
231,700
220,400
134,500
272,700
258,600
278,900
278,900258,600272,700134,500220,400231,700173,400170,500198,700212,800173,400141,100157,400152,300172,000149,600151,400183,600181,000159,800175,700215,200251,300211,100297,100251,800273,900188,000214,500224,600238,100194,800192,827179,642169,214156,153162,287139,903212,902131,771126,297130,642131,565101,347116,626108,94998,58489,15088,68087,39082,52765,41573,70775,56983,51463,51053,26448,96834,36852,00730,60039,90933,41829,62029,66228,49827,26223,06625,57920,50522,56419,38318,80720,19816,60414,67814,76611,06810,1997,85810,6129,18610,4519,9409,65911,78913,1914,4514,2243,1293,1532,6012,3515824524254000200100
       Other Current Assets 
0
100
100
700
726
1,289
502
1,454
335
332
1,968
1,788
1,921
325
533
1,145
716
578
460
557
1,782
1,647
1,788
1,696
1,880
1,635
645
208
367
7,326
114
66
12,317
91
75
19,536
19,750
19,462
10,848
16,427
14,455
3,030
12,873
15,391
16,046
2,985
8,285
6,840
9,358
11,037
6,277
6,188
21,844
24,825
37,390
3,778
5,838
5,013
35,641
46,424
46,288
43,093
107,250
49,444
108,608
142,443
46,202
47,402
42,100
43,500
36,400
59,500
52,900
60,500
62,300
115,500
64,200
57,200
54,900
75,400
81,400
75,700
85,700
133,800
60,200
72,000
47,500
88,300
49,700
87,100
76,000
100,400
60,200
165,800
118,100
219,200
92,600
1,770,100
1,988,300
166,200
166,2001,988,3001,770,10092,600219,200118,100165,80060,200100,40076,00087,10049,70088,30047,50072,00060,200133,80085,70075,70081,40075,40054,90057,20064,200115,50062,30060,50052,90059,50036,40043,50042,10047,40246,202142,443108,60849,444107,25043,09346,28846,42435,6415,0135,8383,77837,39024,82521,8446,1886,27711,0379,3586,8408,2852,98516,04615,39112,8733,03014,45516,42710,84819,46219,75019,536759112,317661147,3263672086451,6351,8801,6961,7881,6471,7825574605787161,1455333251,9211,7881,9683323351,4545021,2897267001001000
   > Long-term Assets 
2,300
2,100
3,700
7,200
11,902
11,775
11,606
28,525
43,237
57,723
111,054
143,119
124,844
30,907
32,318
42,709
71,781
73,466
82,759
89,781
87,752
87,859
87,151
96,666
97,619
107,593
110,282
124,656
118,081
118,170
117,578
201,176
217,345
224,959
225,842
234,557
310,204
397,177
470,757
573,872
635,452
663,793
682,576
727,037
727,958
671,383
684,300
667,148
674,560
701,231
820,920
955,624
987,516
985,794
929,307
958,125
852,788
874,090
994,915
1,178,554
1,124,666
1,071,264
993,565
910,213
900,523
907,783
930,710
909,110
892,500
886,100
883,200
900,800
1,057,200
1,127,800
1,296,800
1,431,500
1,386,600
1,620,700
1,803,400
1,633,000
1,784,200
1,759,100
2,066,200
2,048,900
2,179,600
2,325,000
2,543,000
2,447,800
2,626,700
2,527,000
2,663,000
2,845,500
2,773,200
2,859,000
2,725,200
2,664,200
3,153,000
3,467,900
3,564,700
3,616,000
3,616,0003,564,7003,467,9003,153,0002,664,2002,725,2002,859,0002,773,2002,845,5002,663,0002,527,0002,626,7002,447,8002,543,0002,325,0002,179,6002,048,9002,066,2001,759,1001,784,2001,633,0001,803,4001,620,7001,386,6001,431,5001,296,8001,127,8001,057,200900,800883,200886,100892,500909,110930,710907,783900,523910,213993,5651,071,2641,124,6661,178,554994,915874,090852,788958,125929,307985,794987,516955,624820,920701,231674,560667,148684,300671,383727,958727,037682,576663,793635,452573,872470,757397,177310,204234,557225,842224,959217,345201,176117,578118,170118,081124,656110,282107,59397,61996,66687,15187,85987,75289,78182,75973,46671,78142,70932,31830,907124,844143,119111,05457,72343,23728,52511,60611,77511,9027,2003,7002,1002,300
       Property Plant Equipment 
1,500
1,600
3,200
3,800
3,877
3,917
3,919
5,939
6,023
6,201
6,338
6,403
6,709
6,731
8,585
9,120
10,384
11,183
11,375
15,225
15,199
17,175
17,337
17,799
17,711
20,409
20,392
21,802
22,395
29,638
33,084
34,681
42,071
45,872
56,144
69,354
87,229
115,735
186,849
221,066
255,592
283,006
299,260
303,859
304,642
302,544
303,188
306,044
304,766
314,945
333,225
366,046
401,587
435,751
439,894
453,685
449,076
447,893
449,942
464,950
474,410
477,534
481,049
478,421
474,680
471,862
474,770
495,774
495,200
490,600
488,400
489,300
493,500
501,900
521,700
545,700
577,500
626,100
665,200
699,700
701,200
709,300
678,300
738,500
739,200
744,200
736,400
731,600
713,700
715,700
726,700
780,900
784,400
791,400
840,800
861,500
896,500
938,900
992,200
1,045,400
1,045,400992,200938,900896,500861,500840,800791,400784,400780,900726,700715,700713,700731,600736,400744,200739,200738,500678,300709,300701,200699,700665,200626,100577,500545,700521,700501,900493,500489,300488,400490,600495,200495,774474,770471,862474,680478,421481,049477,534474,410464,950449,942447,893449,076453,685439,894435,751401,587366,046333,225314,945304,766306,044303,188302,544304,642303,859299,260283,006255,592221,066186,849115,73587,22969,35456,14445,87242,07134,68133,08429,63822,39521,80220,39220,40917,71117,79917,33717,17515,19915,22511,37511,18310,3849,1208,5856,7316,7096,4036,3386,2016,0235,9393,9193,9173,8773,8003,2001,6001,500
       Goodwill 
0
0
0
2,700
2,536
2,241
2,094
17,549
17,088
16,587
16,087
15,365
7,465
7,465
7,465
7,465
7,465
7,465
7,465
13,910
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
7,465
10,529
8,763
8,683
8,570
8,697
2,487
2,563
2,589
5,989
8,123
10,918
10,678
10,416
10,530
10,404
10,465
10,626
10,703
10,699
10,666
10,362
10,264
10,264
10,264
10,264
10,264
10,300
10,300
10,300
10,300
10,300
13,700
13,700
13,700
45,600
45,600
28,300
31,500
31,500
31,500
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
28,000
0
0
0
33,700
33,70000028,00028,00028,00028,00028,00028,00028,00028,00028,00028,00028,00028,00028,00028,00031,50031,50031,50028,30045,60045,60013,70013,70013,70010,30010,30010,30010,30010,30010,26410,26410,26410,26410,26410,36210,66610,69910,70310,62610,46510,40410,53010,41610,67810,9188,1235,9892,5892,5632,4878,6978,5708,6838,76310,5297,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,46513,9107,4657,4657,4657,4657,4657,4657,46515,36516,08716,58717,08817,5492,0942,2412,5362,700000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
135,285
164,167
132,849
141,212
157,198
249,995
343,899
336,961
308,944
248,884
305,726
206,123
198,077
321,940
448,134
384,140
280,887
205,953
122,658
116,493
121,467
91,706
38,002
10,700
3,900
2,300
2,300
144,500
216,200
338,500
502,700
414,800
578,300
595,900
442,600
411,300
420,700
730,400
767,500
868,000
1,009,400
1,227,500
1,149,600
1,433,500
1,325,400
1,508,700
1,649,900
1,559,100
1,641,900
1,443,800
1,316,200
1,765,600
2,023,600
2,060,800
1,909,800
1,909,8002,060,8002,023,6001,765,6001,316,2001,443,8001,641,9001,559,1001,649,9001,508,7001,325,4001,433,5001,149,6001,227,5001,009,400868,000767,500730,400420,700411,300442,600595,900578,300414,800502,700338,500216,200144,5002,3002,3003,90010,70038,00291,706121,467116,493122,658205,953280,887384,140448,134321,940198,077206,123305,726248,884308,944336,961343,899249,995157,198141,212132,849164,167135,285000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
2,700
2,536
2,241
2,094
17,549
17,088
16,587
16,087
15,365
7,670
14,903
14,674
14,466
14,558
14,343
14,128
13,910
13,791
13,671
13,552
13,432
13,312
13,192
13,072
12,952
3,382
3,302
3,221
3,140
2,985
2,829
1,160
962
814
667
520
373
335
297
8,887
9,655
8,671
7,513
7,970
7,374
7,429
7,162
13,413
13,964
13,997
6,386
6,246
5,878
5,253
4,474
3,988
3,412
3,038
4,670
4,137
19,201
18,871
18,541
18,269
18,114
24,000
23,800
23,700
23,500
23,300
32,100
32,000
31,900
45,600
45,600
139,400
139,300
139,300
130,400
130,400
130,300
130,300
130,200
130,200
130,100
16,700
16,700
16,700
16,600
16,600
16,600
16,500
16,500
44,500
44,500
44,400
80,500
80,50044,40044,50044,50016,50016,50016,60016,60016,60016,70016,70016,700130,100130,200130,200130,300130,300130,400130,400139,300139,300139,40045,60045,60031,90032,00032,10023,30023,50023,70023,80024,00018,11418,26918,54118,87119,2014,1374,6703,0383,4123,9884,4745,2535,8786,2466,38613,99713,96413,4137,1627,4297,3747,9707,5138,6719,6558,8872973353735206678149621,1602,8292,9853,1403,2213,3023,38212,95213,07213,19213,31213,43213,55213,67113,79113,91014,12814,34314,55814,46614,67414,9037,67015,36516,08716,58717,08817,5492,0942,2412,5362,700000
       Long-term Assets Other 
800
500
500
700
5,488
5,616
5,593
5,037
20,126
34,935
88,629
121,350
103,000
9,273
9,059
19,123
46,839
47,940
57,256
60,646
58,762
57,013
56,262
65,435
66,596
73,992
76,818
74,802
39,871
45,589
44,694
89,003
52,645
52,477
51,541
53,336
52,878
53,603
57,551
22,974
21,587
21,651
16,593
15,187
13,635
7,805
8,135
11,137
20,905
26,187
27,298
27,724
28,050
28,113
28,071
26,782
26,596
57,961
53,416
53,268
53,076
103,699
98,411
97,819
97,499
102,930
153,101
154,280
159,800
169,400
169,700
197,100
204,100
185,900
213,000
224,100
235,300
257,300
261,700
224,200
235,400
202,900
231,000
154,600
168,000
167,400
165,400
169,900
171,200
177,000
109,000
108,200
113,300
105,800
114,800
114,300
124,500
135,300
141,700
151,800
151,800141,700135,300124,500114,300114,800105,800113,300108,200109,000177,000171,200169,900165,400167,400168,000154,600231,000202,900235,400224,200261,700257,300235,300224,100213,000185,900204,100197,100169,700169,400159,800154,280153,101102,93097,49997,81998,411103,69953,07653,26853,41657,96126,59626,78228,07128,11328,05027,72427,29826,18720,90511,1378,1357,80513,63515,18716,59321,65121,58722,97457,55153,60352,87853,33651,54152,47752,64589,00344,69445,58939,87174,80276,81873,99266,59665,43556,26257,01358,76260,64657,25647,94046,83919,1239,0599,273103,000121,35088,62934,93520,1265,0375,5935,6165,488700500500800
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169,478
151,872
202,135
192,563
193,150
191,000
190,745
190,634
190,529
190,448
150,147
149,951
149,813
149,648
192,718
193,910
193,808
193,653
181,721
182,716
182,719
182,600
192,676
192,500
188,100
188,800
178,300
181,500
178,000
177,900
113,400
113,400
113,400
112,900
95,700
265,500
0
268,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000268,1000265,50095,700112,900113,400113,400113,400177,900178,000181,500178,300188,800188,100192,500192,676182,600182,719182,716181,721193,653193,808193,910192,718149,648149,813149,951150,147190,448190,529190,634190,745191,000193,150192,563202,135151,872169,478000000000000000000000000000000000000000000000
> Total Liabilities 
2,300
1,600
4,100
6,300
6,822
8,562
9,668
15,907
16,207
16,246
14,505
15,722
11,396
14,568
13,364
12,908
13,669
15,202
18,536
11,737
10,986
12,665
15,771
15,522
13,615
17,426
18,816
16,311
19,465
25,914
22,728
273,944
273,914
292,793
302,176
291,228
311,631
305,529
348,094
363,620
325,531
346,691
365,170
398,535
398,455
405,374
442,053
547,749
561,195
576,397
582,084
569,591
536,786
546,802
586,661
531,732
535,769
561,534
619,542
783,256
757,244
739,797
855,491
618,836
782,560
683,265
679,864
584,798
469,300
384,400
419,600
463,400
485,100
896,200
846,900
777,600
631,600
660,100
700,100
612,400
1,388,500
1,332,100
1,283,800
1,133,000
1,077,400
1,125,700
1,128,100
1,219,800
1,195,600
1,205,400
1,219,200
1,210,200
1,183,500
1,224,900
1,219,400
1,247,800
1,222,800
1,270,300
1,311,500
1,182,200
1,182,2001,311,5001,270,3001,222,8001,247,8001,219,4001,224,9001,183,5001,210,2001,219,2001,205,4001,195,6001,219,8001,128,1001,125,7001,077,4001,133,0001,283,8001,332,1001,388,500612,400700,100660,100631,600777,600846,900896,200485,100463,400419,600384,400469,300584,798679,864683,265782,560618,836855,491739,797757,244783,256619,542561,534535,769531,732586,661546,802536,786569,591582,084576,397561,195547,749442,053405,374398,455398,535365,170346,691325,531363,620348,094305,529311,631291,228302,176292,793273,914273,94422,72825,91419,46516,31118,81617,42613,61515,52215,77112,66510,98611,73718,53615,20213,66912,90813,36414,56811,39615,72214,50516,24616,20715,9079,6688,5626,8226,3004,1001,6002,300
   > Total Current Liabilities 
2,000
900
2,300
4,600
5,032
6,781
7,891
11,492
12,135
11,916
9,583
10,798
7,928
11,054
9,796
9,307
11,045
12,466
17,451
10,618
9,823
11,302
14,187
13,864
11,925
15,755
17,123
14,523
17,708
23,854
20,005
19,250
19,228
23,308
32,793
272,760
60,452
293,221
293,127
57,826
59,761
76,217
301,027
330,187
329,038
365,724
397,465
428,686
441,954
453,541
424,951
212,577
175,542
187,662
227,615
176,755
176,604
412,225
468,909
687,674
658,535
659,073
760,648
504,310
646,748
542,414
557,342
440,824
357,100
292,400
314,600
332,500
427,700
838,800
789,400
444,700
318,400
350,000
372,400
276,600
270,000
463,500
469,900
463,000
207,300
255,000
258,900
323,300
302,400
311,400
320,000
305,400
292,600
331,500
315,900
343,200
324,600
370,300
744,100
804,400
804,400744,100370,300324,600343,200315,900331,500292,600305,400320,000311,400302,400323,300258,900255,000207,300463,000469,900463,500270,000276,600372,400350,000318,400444,700789,400838,800427,700332,500314,600292,400357,100440,824557,342542,414646,748504,310760,648659,073658,535687,674468,909412,225176,604176,755227,615187,662175,542212,577424,951453,541441,954428,686397,465365,724329,038330,187301,02776,21759,76157,826293,127293,22160,452272,76032,79323,30819,22819,25020,00523,85417,70814,52317,12315,75511,92513,86414,18711,3029,82310,61817,45112,46611,0459,3079,79611,0547,92810,7989,58311,91612,13511,4927,8916,7815,0324,6002,3009002,000
       Short-term Debt 
0
0
0
100
44
42
29
71
78
86
100
102
104
107
111
111
1,091
1,095
2,478
773
22
20
18
16
10
795
586
15
12
9
5
10
11
12
12
250,012
22,000
249,978
249,978
0
0
0
216,525
220,272
224,090
258,854
263,084
235,968
240,080
244,269
248,537
0
0
0
0
0
0
210,166
212,967
282,458
285,353
363,326
291,315
126,481
115,222
32,282
30,017
5,387
5,400
900
0
0
0
250,000
250,000
250,000
250,000
250,000
0
0
3,400
250,000
250,000
250,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300,000
400,000
400,000300,00000000000000000250,000250,000250,0003,40000250,000250,000250,000250,000250,0000009005,4005,38730,01732,282115,222126,481291,315363,326285,353282,458212,967210,166000000248,537244,269240,080235,968263,084258,854224,090220,272216,525000249,978249,97822,000250,0121212111059121558679510161820227732,4781,0951,091111111107104102100867871294244100000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
126,414
0
0
0
5,400
0
900
0
0
0
250,000
250,000
250,000
250,000
250,000
0
0
3,400
250,000
250,000
250,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300,000
400,000
400,000300,00000000000000000250,000250,000250,0003,40000250,000250,000250,000250,000250,00000090005,400000126,414000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,700
700
2,200
2,300
2,877
3,342
3,329
5,952
6,957
6,096
5,173
6,667
3,428
5,933
3,922
2,988
2,810
3,056
4,413
4,326
3,338
2,643
2,661
6,127
3,057
3,881
4,063
3,980
4,672
4,400
3,649
3,093
4,967
5,096
13,994
2,000
16,475
14,774
16,113
20,334
10,512
19,696
17,688
18,750
6,550
9,349
11,296
16,146
10,038
17,082
17,244
47,257
8,335
8,695
10,130
10,203
10,194
9,377
97,510
6,708
104,015
112,246
127,961
6,995
90,130
110,110
113,346
7,502
106,600
124,000
119,000
8,100
105,600
126,800
143,300
8,400
203,400
216,000
204,800
23,100
139,400
163,900
161,100
9,900
130,300
152,600
177,000
4,100
165,000
189,800
210,500
3,800
166,400
196,600
220,100
4,100
239,700
292,000
333,400
5,600
5,600333,400292,000239,7004,100220,100196,600166,4003,800210,500189,800165,0004,100177,000152,600130,3009,900161,100163,900139,40023,100204,800216,000203,4008,400143,300126,800105,6008,100119,000124,000106,6007,502113,346110,11090,1306,995127,961112,246104,0156,70897,5109,37710,19410,20310,1308,6958,33547,25717,24417,08210,03816,14611,2969,3496,55018,75017,68819,69610,51220,33416,11314,77416,4752,00013,9945,0964,9673,0933,6494,4004,6723,9804,0633,8813,0576,1272,6612,6433,3384,3264,4133,0562,8102,9883,9225,9333,4286,6675,1736,0966,9575,9523,3293,3422,8772,3002,2007001,700
       Other Current Liabilities 
300
200
100
2,200
2,111
3,398
4,533
5,469
1,232
1,026
513
575
1,580
2,174
1,976
1,757
1,141
1,094
1,108
60
61
1,046
1,065
32
8,858
72
41
134
75
3,256
1,862
882
436
504
997
2,806
3,444
3,696
5,415
37,492
49,249
56,521
39,814
61,401
65,763
55,632
77,543
126,292
139,018
130,235
89,542
165,320
167,207
178,967
217,485
166,552
166,410
110,955
158,432
25,016
61,381
19,074
469,333
10,346
48,964
45,243
199,962
57,462
103,100
46,600
195,600
324,400
322,100
270,000
251,000
436,300
115,000
134,000
167,600
253,500
270,000
213,500
219,900
39,600
207,300
255,000
81,900
319,200
302,400
311,400
320,000
301,600
292,600
134,900
95,800
339,100
84,900
78,300
444,100
71,000
71,000444,10078,30084,900339,10095,800134,900292,600301,600320,000311,400302,400319,20081,900255,000207,30039,600219,900213,500270,000253,500167,600134,000115,000436,300251,000270,000322,100324,400195,60046,600103,10057,462199,96245,24348,96410,346469,33319,07461,38125,016158,432110,955166,410166,552217,485178,967167,207165,32089,542130,235139,018126,29277,54355,63265,76361,40139,81456,52149,24937,4925,4153,6963,4442,8069975044368821,8623,2567513441728,858321,0651,04661601,1081,0941,1411,7571,9762,1741,5805755131,0261,2325,4694,5333,3982,1112,200100200300
   > Long-term Liabilities 
300
700
1,800
1,700
1,790
1,780
1,777
4,415
4,073
4,330
4,922
4,924
3,468
3,514
3,568
3,601
2,624
2,736
1,085
1,119
1,163
1,363
1,584
1,658
1,690
1,671
1,693
1,788
1,757
2,060
2,723
254,694
254,686
269,485
269,383
18,468
251,179
12,308
54,967
305,794
265,770
270,474
64,143
68,348
69,417
39,650
44,588
119,063
119,241
122,856
157,133
357,014
361,244
359,140
359,046
354,977
359,165
149,309
150,633
95,582
98,709
80,724
94,843
114,526
135,812
140,851
122,522
143,974
112,200
92,000
105,000
130,900
57,400
57,400
57,500
313,700
313,200
310,100
327,700
316,600
1,118,500
868,600
813,900
670,000
870,100
870,700
869,200
896,500
893,200
894,000
899,200
904,800
890,900
893,400
903,500
904,600
898,200
900,000
567,400
377,800
377,800567,400900,000898,200904,600903,500893,400890,900904,800899,200894,000893,200896,500869,200870,700870,100670,000813,900868,6001,118,500316,600327,700310,100313,200313,70057,50057,40057,400130,900105,00092,000112,200143,974122,522140,851135,812114,52694,84380,72498,70995,582150,633149,309359,165354,977359,046359,140361,244357,014157,133122,856119,241119,06344,58839,65069,41768,34864,143270,474265,770305,79454,96712,308251,17918,468269,383269,485254,686254,6942,7232,0601,7571,7881,6931,6711,6901,6581,5841,3631,1631,1191,0852,7362,6243,6013,5683,5143,4684,9244,9224,3304,0734,4151,7771,7801,7901,7001,800700300
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,929
68,929
68,929
68,929
265,632
268,164
270,759
273,370
275,010
277,699
70,320
70,298
3,724
3,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
250,000
250,000
250,000
250,000
250,000
1,050,000
800,000
750,000
600,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
800,000
0
0
00800,000800,000800,000800,000800,000800,000800,000800,000800,000800,000800,000800,000800,000800,000600,000750,000800,0001,050,000250,000250,000250,000250,000250,000000000000000003,7003,72470,29870,320277,699275,010273,370270,759268,164265,63268,92968,92968,92968,92900000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169,478
151,872
202,135
192,563
193,150
191,000
190,745
190,634
190,529
190,448
150,147
149,951
149,813
149,648
192,718
193,910
193,808
193,653
181,721
182,716
182,719
182,600
192,676
192,500
188,100
188,800
178,300
181,500
178,000
177,900
113,400
113,400
113,400
112,900
95,700
265,500
0
268,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000268,1000265,50095,700112,900113,400113,400113,400177,900178,000181,500178,300188,800188,100192,500192,676182,600182,719182,716181,721193,653193,808193,910192,718149,648149,813149,951150,147190,448190,529190,634190,745191,000193,150192,563202,135151,872169,478000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,882
10,882
10,882
10,882
10,882
10,882
10,882
10,882
10,882
10,882
10,882
10,882
50,716
47,915
45,037
42,143
39,170
36,180
23,218
20,431
13,084
12,499
11,095
11,000
10,900
10,900
10,900
10,900
19,200
19,200
19,200
19,200
19,200
19,200
19,200
19,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000019,20019,20019,20019,20019,20019,20019,20019,20010,90010,90010,90010,90011,00011,09512,49913,08420,43123,21836,18039,17042,14345,03747,91550,71610,88210,88210,88210,88210,88210,88210,88210,88210,88210,88210,88210,882000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
14
14
14
2,579
2,229
2,493
3,059
3,088
1,654
1,715
1,787
1,834
872
997
1,054
1,094
1,143
1,347
1,571
1,648
1,680
1,657
1,684
1,780
1,750
2,055
2,719
3,100
4,675
8,595
8,497
7,584
12,297
12,308
15,085
15,673
16,129
16,957
23,204
27,139
27,935
28,768
33,706
39,252
39,430
43,045
77,322
80,500
82,198
77,499
74,794
79,967
81,466
78,989
80,335
91,858
95,009
80,724
94,843
114,526
135,812
140,851
122,522
143,974
112,200
92,000
105,000
130,900
57,400
57,400
57,500
63,700
82,400
79,300
96,900
85,800
84,000
73,000
61,100
67,000
70,100
70,700
69,200
79,400
93,200
94,000
99,200
104,800
90,900
93,400
103,500
76,800
98,200
0
0
0
00098,20076,800103,50093,40090,900104,80099,20094,00093,20079,40069,20070,70070,10067,00061,10073,00084,00085,80096,90079,30082,40063,70057,50057,40057,400130,900105,00092,000112,200143,974122,522140,851135,812114,52694,84380,72495,00991,85880,33578,98981,46679,96774,79477,49982,19880,50077,32243,04539,43039,25233,70628,76827,93527,13923,20416,95716,12915,67315,08512,30812,2977,5848,4978,5954,6753,1002,7192,0551,7501,7801,6841,6571,6801,6481,5711,3471,1431,0941,0549978721,8341,7871,7151,6543,0883,0592,4932,2292,5791414140000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,600
8,800
0
0
0
9,300
8,600
7,900
7,200
9,300
8,700
8,100
7,500
6,900
12,900
12,100
11,300
10,500
0
0
0
0
000010,50011,30012,10012,9006,9007,5008,1008,7009,3007,2007,9008,6009,3000008,8009,600000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
15,500
58,300
59,400
53,600
123,583
114,811
242,773
234,738
224,791
213,595
203,573
196,399
190,802
186,036
174,109
171,658
168,311
169,466
169,550
167,765
165,054
170,585
179,339
191,636
203,310
216,798
238,357
275,102
285,286
299,519
275,046
204,606
162,352
179,001
210,542
295,790
326,433
363,407
418,586
507,699
577,282
604,980
639,557
653,009
728,248
782,301
840,731
883,886
924,209
1,002,343
1,084,969
948,488
1,024,649
1,009,599
1,060,831
1,094,863
1,161,586
1,216,139
1,308,115
1,304,311
1,357,690
1,213,075
1,216,559
1,265,574
1,112,054
1,053,557
1,479,369
1,599,647
1,722,800
1,817,100
1,849,600
1,862,200
2,076,200
1,795,300
2,089,100
2,101,800
2,388,600
2,584,800
2,712,000
2,788,600
2,338,200
2,566,800
2,715,800
2,780,400
2,948,500
3,093,700
3,283,100
3,395,200
3,445,400
3,639,500
3,829,700
3,958,900
4,176,300
4,318,400
4,562,200
4,796,700
5,123,200
5,411,000
5,712,100
5,984,800
5,984,8005,712,1005,411,0005,123,2004,796,7004,562,2004,318,4004,176,3003,958,9003,829,7003,639,5003,445,4003,395,2003,283,1003,093,7002,948,5002,780,4002,715,8002,566,8002,338,2002,788,6002,712,0002,584,8002,388,6002,101,8002,089,1001,795,3002,076,2001,862,2001,849,6001,817,1001,722,8001,599,6471,479,3691,053,5571,112,0541,265,5741,216,5591,213,0751,357,6901,304,3111,308,1151,216,1391,161,5861,094,8631,060,8311,009,5991,024,649948,4881,084,9691,002,343924,209883,886840,731782,301728,248653,009639,557604,980577,282507,699418,586363,407326,433295,790210,542179,001162,352204,606275,046299,519285,286275,102238,357216,798203,310191,636179,339170,585165,054167,765169,550169,466168,311171,658174,109186,036190,802196,399203,573213,595224,791234,738242,773114,811123,58353,60059,40058,30015,500
   Common Stock
0
200
200
200
186
189
202
207
207
208
208
208
208
214
214
215
215
217
218
218
219
220
228
229
231
233
236
239
240
242
245
246
251
254
256
266
269
271
276
276
277
278
282
567
581
589
592
600
605
608
608
615
616
617
619
621
623
625
628
630
633
638
642
660
665
682
685
690
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
700
7007007007007007007007007007007007007007007007007007007007007007007007007007007007007007007007006906856826656606426386336306286256236216196176166156086086056005925895815672822782772762762712692662562542512462452422402392362332312292282202192182182172152152142142082082082082072072021891862002002000
   Retained Earnings 
-28,000
-34,100
-40,500
-49,300
-57,185
-85,995
-93,009
-124,882
-134,285
-144,932
-154,743
-162,170
-167,847
-171,029
-183,216
-185,821
-188,845
-191,229
-192,570
-195,390
-197,637
-193,497
-187,231
-180,341
-172,680
-160,498
-144,735
-115,325
-113,018
-105,345
-96,867
-41,360
-44,141
-38,335
-23,487
-21,501
-10,098
4,232
16,855
-78,514
-79,777
-83,072
-71,135
-74,746
-55,817
-18,110
21,626
31,170
47,560
121,451
205,849
249,038
319,798
392,114
470,225
553,480
615,805
695,669
758,354
728,040
865,564
977,416
952,179
1,068,114
1,051,473
1,150,684
1,615,109
1,719,753
1,955,300
2,161,400
2,323,200
2,433,500
2,606,300
2,550,300
2,826,600
2,845,600
3,090,100
3,263,000
3,369,500
3,434,800
2,935,100
3,140,200
3,272,600
3,325,200
3,462,100
3,569,200
3,740,400
3,839,200
3,867,500
4,040,100
4,202,800
4,315,000
4,554,900
4,670,900
4,910,200
5,042,300
5,283,200
5,542,400
5,810,000
6,027,100
6,027,1005,810,0005,542,4005,283,2005,042,3004,910,2004,670,9004,554,9004,315,0004,202,8004,040,1003,867,5003,839,2003,740,4003,569,2003,462,1003,325,2003,272,6003,140,2002,935,1003,434,8003,369,5003,263,0003,090,1002,845,6002,826,6002,550,3002,606,3002,433,5002,323,2002,161,4001,955,3001,719,7531,615,1091,150,6841,051,4731,068,114952,179977,416865,564728,040758,354695,669615,805553,480470,225392,114319,798249,038205,849121,45147,56031,17021,626-18,110-55,817-74,746-71,135-83,072-79,777-78,51416,8554,232-10,098-21,501-23,487-38,335-44,141-41,360-96,867-105,345-113,018-115,325-144,735-160,498-172,680-180,341-187,231-193,497-197,637-195,390-192,570-191,229-188,845-185,821-183,216-171,029-167,847-162,170-154,743-144,932-134,285-124,882-93,009-85,995-57,185-49,300-40,500-34,100-28,000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
874,434
892,105
928,690
953,528
958,957
959,302
992,718
996,773
998,778
1,013,434
1,015,835
1,028,141
999,681
1,029,718
1,057,224
1,076,061
1,101,476
1,161,083
1,376,141
1,426,998
1,694,973
1,723,888
1,790,620
1,801,100
1,826,700
1,836,700
1,813,500
1,801,400
1,785,500
1,838,600
1,854,300
1,879,500
1,903,000
1,924,000
1,940,200
1,967,600
2,001,700
2,025,800
2,047,900
2,068,400
2,105,100
2,125,700
2,148,700
2,173,200
2,196,500
2,225,500
2,245,400
2,254,200
2,291,500
2,314,600
2,388,400
2,457,300
2,497,700
0
0
002,497,7002,457,3002,388,4002,314,6002,291,5002,254,2002,245,4002,225,5002,196,5002,173,2002,148,7002,125,7002,105,1002,068,4002,047,9002,025,8002,001,7001,967,6001,940,2001,924,0001,903,0001,879,5001,854,3001,838,6001,785,5001,801,4001,813,5001,836,7001,826,7001,801,1001,790,6201,723,8881,694,9731,426,9981,376,1411,161,0831,101,4761,076,0611,057,2241,029,718999,6811,028,1411,015,8351,013,434998,778996,773992,718959,302958,957953,528928,690892,105874,434000000000000000000000000000000000000000000000
   Treasury Stock000000000000000-2,579,200-2,579,200-2,579,200-2,579,200-2,579,200-2,579,200-2,579,200-2,579,200-2,579,200-2,579,200-2,579,200-2,543,800-2,326,400-2,379,600-2,305,100-2,167,900-2,025,500-1,902,110-1,850,882-1,785,936-1,365,870-1,185,825-916,595-890,998-611,070-513,437-513,437-513,437-476,902-470,998-413,923-370,998-282,998-282,998-70,149-70,149-70,149-67,399-67,399-67,395-67,395-67,395-67,395-67,395-67,395-67,395-231,619-231,619-231,619-231,619-231,619-231,619-231,619-164,560-49,105-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,874-6,531-5,068-4,0720000000
   Other Stockholders Equity 
43,500
92,200
99,800
102,900
180,856
200,969
336,019
359,904
359,360
358,810
358,600
359,728
359,808
358,218
358,478
357,256
357,305
359,695
361,245
361,263
362,384
363,386
366,423
369,071
371,718
375,237
380,846
386,595
394,803
401,731
370,069
244,244
194,180
213,286
233,087
316,708
337,922
360,931
405,056
591,850
663,590
690,501
714,040
731,502
789,416
807,039
824,706
861,291
883,379
888,808
889,153
709,720
713,775
627,780
599,511
544,837
551,239
486,244
516,281
543,787
464,991
210,478
244,488
190,316
61,128
-90,963
-126,994
-111,490
-224,400
-341,200
-468,400
-566,100
-525,000
-758,300
-740,600
-744,100
-699,700
-676,200
-655,200
-658,200
-611,600
-577,500
-553,400
-531,300
-510,800
-474,100
-453,500
-429,600
-406,000
-382,700
-353,700
-333,800
-325,000
-287,700
-264,600
-190,800
-121,900
-81,500
-54,900
-30,200
-30,200-54,900-81,500-121,900-190,800-264,600-287,700-325,000-333,800-353,700-382,700-406,000-429,600-453,500-474,100-510,800-531,300-553,400-577,500-611,600-658,200-655,200-676,200-699,700-744,100-740,600-758,300-525,000-566,100-468,400-341,200-224,400-111,490-126,994-90,96361,128190,316244,488210,478464,991543,787516,281486,244551,239544,837599,511627,780713,775709,720889,153888,808883,379861,291824,706807,039789,416731,502714,040690,501663,590591,850405,056360,931337,922316,708233,087213,286194,180244,244370,069401,731394,803386,595380,846375,237371,718369,071366,423363,386362,384361,263361,245359,695357,305357,256358,478358,218359,808359,728358,600358,810359,360359,904336,019200,969180,856102,90099,80092,20043,500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,327,500
Cost of Revenue-257,500
Gross Profit2,070,0002,070,000
 
Operating Income (+$)
Gross Profit2,070,000
Operating Expense-885,100
Operating Income1,184,9001,184,900
 
Operating Expense (+$)
Research Development408,000
Selling General Administrative395,300
Selling And Marketing Expenses81,800
Operating Expense885,100885,100
 
Net Interest Income (+$)
Interest Income162,700
Interest Expense-59,300
Other Finance Cost-0
Net Interest Income103,400
 
Pretax Income (+$)
Operating Income1,184,900
Net Interest Income103,400
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,274,3001,198,900
EBIT - interestExpense = 1,274,300
1,274,300
1,044,100
Interest Expense59,300
Earnings Before Interest and Taxes (EBIT)1,333,6001,333,600
Earnings Before Interest and Taxes (EBITDA)1,386,800
 
After tax Income (+$)
Income Before Tax1,274,300
Tax Provision-289,500
Net Income From Continuing Ops984,800984,800
Net Income984,800
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,142,600
Total Other Income/Expenses Net-14,000-103,400
 

Technical Analysis of United Therapeutics Corporation
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of United Therapeutics Corporation. The general trend of United Therapeutics Corporation is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine United Therapeutics Corporation's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of United Therapeutics Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 241.37 < 250.36 < 250.89.

The bearish price targets are: 221.53 > 210.00 > 208.62.

Tweet this
United Therapeutics Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of United Therapeutics Corporation. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

United Therapeutics Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of United Therapeutics Corporation. The current macd is 0.55888467.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the United Therapeutics Corporation price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for United Therapeutics Corporation. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the United Therapeutics Corporation price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
United Therapeutics Corporation Daily Moving Average Convergence/Divergence (MACD) ChartUnited Therapeutics Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of United Therapeutics Corporation. The current adx is 15.86.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy United Therapeutics Corporation shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
United Therapeutics Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of United Therapeutics Corporation. The current sar is 221.53.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
United Therapeutics Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of United Therapeutics Corporation. The current rsi is 53.27. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
United Therapeutics Corporation Daily Relative Strength Index (RSI) ChartUnited Therapeutics Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of United Therapeutics Corporation. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the United Therapeutics Corporation price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
United Therapeutics Corporation Daily Stochastic Oscillator ChartUnited Therapeutics Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of United Therapeutics Corporation. The current cci is 28.47.

United Therapeutics Corporation Daily Commodity Channel Index (CCI) ChartUnited Therapeutics Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of United Therapeutics Corporation. The current cmo is 8.15481069.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
United Therapeutics Corporation Daily Chande Momentum Oscillator (CMO) ChartUnited Therapeutics Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of United Therapeutics Corporation. The current willr is -22.37903226.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that United Therapeutics Corporation is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
United Therapeutics Corporation Daily Williams %R ChartUnited Therapeutics Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of United Therapeutics Corporation.

United Therapeutics Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of United Therapeutics Corporation. The current atr is 6.38421017.

United Therapeutics Corporation Daily Average True Range (ATR) ChartUnited Therapeutics Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of United Therapeutics Corporation. The current obv is 4,051,991.

United Therapeutics Corporation Daily On-Balance Volume (OBV) ChartUnited Therapeutics Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of United Therapeutics Corporation. The current mfi is 68.61.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
United Therapeutics Corporation Daily Money Flow Index (MFI) ChartUnited Therapeutics Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for United Therapeutics Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

United Therapeutics Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of United Therapeutics Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.271
Ma 20Greater thanMa 50235.810
Ma 50Greater thanMa 100230.761
Ma 100Greater thanMa 200229.244
OpenGreater thanClose234.670
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of United Therapeutics Corporation with someone you think should read this too:
  • Are you bullish or bearish on United Therapeutics Corporation? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about United Therapeutics Corporation? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about United Therapeutics Corporation

I send you an email if I find something interesting about United Therapeutics Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about United Therapeutics Corporation.

Receive notifications about United Therapeutics Corporation in your mailbox!